GSK (NYSE: GSK) president acquires ADS in savings plan
Rhea-AI Filing Summary
GSK plc (GSK) reports a transaction by senior management under its executive savings plan. Maya Martinez-Davis, President, acquired 9.221 notional American Depositary Shares (ADS) of GSK within her GSK Executive Supplemental Savings Plan account at a price of $51.7800 per ADS. The transaction took place on 24 August 2026 on the New York Stock Exchange (XNYS). The filing classifies this as an acquisition of notional ADS rather than a direct market trade.
Positive
- None.
Negative
- None.
Key Figures
ADS price: $51.7800 per ADS
ADS volume: 9.221 ADS
Transaction date: 2026-08-24
3 metrics
ADS price
$51.7800 per ADS
Price of American Depositary Shares acquired by Maya Martinez-Davis
ADS volume
9.221 ADS
Volume of notional ADS acquired within the GSK Executive Supplemental Savings Plan account
Transaction date
2026-08-24
Date of the acquisition of notional ADS reported for the GSK President
Key Terms
PDMR, American Depositary Shares, Executive Supplemental Savings Plan, Legal Entity Identifier
4 terms
PDMR regulatory
"Details of PDMR/person closely associated with them ('PCA')"
A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.
Executive Supplemental Savings Plan financial
"Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan"
Legal Entity Identifier regulatory
"LEI | 5493000HZTVUYLO1D793"
A legal entity identifier (LEI) is a unique, standardized code that functions like a global ID card for businesses and organizations involved in financial markets. It helps investors and regulators reliably identify who is on the other side of a deal, trace ownership and links between firms, and reduce confusion or fraud — improving transparency for reporting, risk assessment, and cross-border trades.
FAQ
Who is the person involved in the disclosed transaction at GSK (GSK)?
The person involved is Maya Martinez-Davis, identified as President at GSK. The notification is described as an initial notification of a transaction related to her executive supplemental savings plan account.
What type of security was involved in the GSK (GSK) executive transaction?
The security is American Depositary Shares (ADS) of GSK, identified with ISIN US37733W2044. The filing describes the event as an acquisition of notional ADS within an executive supplemental savings plan.
At what price and volume were the GSK (GSK) ADS acquired in this transaction?
The filing reports a single transaction with a price of $51.7800 per ADS and a volume of 9.221 notional ADS acquired within Maya Martinez-Davis’s GSK Executive Supplemental Savings Plan account.
On what date and where did the reported GSK (GSK) ADS transaction occur?
The transaction occurred on 24 August 2026 and is reported as having been conducted on the New York Stock Exchange (XNYS), according to the details provided in the notification.
Is this GSK (GSK) transaction part of a larger aggregated set of trades?
No. The filing states that the aggregated information is N/A (single transaction), indicating that this disclosure relates to one specific acquisition of notional ADS rather than multiple combined trades.
AI-generated analysis. How Rhea-AI works. Not financial advice.
